Repligen Newsroom

Repligen Initiated at Hold by Canaccord Genuity

Dow JonesDec 18 00:10

Repligen Analyst Ratings

BenzingaDec 18 00:00

CCORF Initiates Repligen(RGEN.US) With Hold Rating, Announces Target Price $165

Futu NewsDec 17 05:31

RBC Capital Reaffirms Their Buy Rating on Repligen (RGEN)

TipRanksDec 11 09:53

RBC Lifts Price Target on Repligen to $207 From $205, Keeps Outperform Rating

MT NewswiresDec 9 20:14

Repligen Analyst Ratings

BenzingaNov 14 21:44

Wolfe Research Initiates Repligen(RGEN.US) With Hold Rating

Futu NewsNov 14 20:31

Benchmark Co. Maintains Repligen(RGEN.US) With Hold Rating

Futu NewsNov 13 21:36

Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207

Futu NewsNov 13 21:36

Repligen (RGEN) Receives a Hold From Benchmark Co.

TipRanksNov 13 21:27

RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $205

Futu NewsNov 13 20:35

KeyBanc Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $220

Futu NewsNov 13 10:32

Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating

Futu NewsNov 12 22:31

Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating

Futu NewsNov 11 22:31

Craig-Hallum Remains a Buy on Repligen (RGEN)

TipRanksNov 11 21:37

RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $205

Futu NewsOct 25 10:31

J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $190

Futu NewsOct 15 20:33

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and Repligen (RGEN)

TipRanksSep 27 20:42

Repligen Analyst Ratings

BenzingaSep 26 22:19

RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $205

Futu NewsSep 26 19:33